Table of Content

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Breast Cancer Diagnostics Market, by Region, 2018-2026 (USD Billion)
1.2.2. Breast Cancer Diagnostics Market, by Diagnostic Type, 2018-2026 (USD Billion)
1.2.3. Breast Cancer Diagnostics Market, by End-User, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Breast Cancer Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Breast Cancer Diagnostics Market Dynamics
3.1. Breast Cancer Diagnostics Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Breast Cancer Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Breast Cancer Diagnostics Market, by Diagnostic Type
5.1. Market Snapshot
5.2. Global Breast Cancer Diagnostics Market by Diagnostic Type, Performance - Potential Analysis
5.3. Global Breast Cancer Diagnostics Market Estimates & Forecasts by Diagnostic Type 2016-2026 (USD Billion)
5.4. Breast Cancer Diagnostics Market, Sub Segment Analysis
5.4.1. Ionizing breast imaging technologies
5.4.2. Non-ionizing imaging technologies
Chapter 6. Global Breast Cancer Diagnostics Market, by End-User
6.1. Market Snapshot
6.2. Global Breast Cancer Diagnostics Market by End-User, Performance - Potential Analysis
6.3. Global Breast Cancer Diagnostics Market Estimates & Forecasts by End-User 2016-2026 (USD Billion)
6.4. Breast Cancer Diagnostics Market, Sub Segment Analysis
6.4.1. Hospitals
6.4.2. Cancer research centers/institutes
6.4.3. Diagnostic Clinical laboratories
6.4.4. Ambulatory Surgical centers
Chapter 7. Global Breast Cancer Diagnostics Market, Regional Analysis
7.1. Breast Cancer Diagnostics Market, Regional Market Snapshot
7.2. North America Breast Cancer Diagnostics Market
7.2.1. U.S. Breast Cancer Diagnostics Market
7.2.1.1. Diagnostic Type breakdown estimates & forecasts, 2016-2026
7.2.1.2. End-User breakdown estimates & forecasts, 2016-2026
7.2.2. Canada Breast Cancer Diagnostics Market
7.3. Europe Breast Cancer Diagnostics Market Snapshot
7.3.1. U.K. Breast Cancer Diagnostics Market
7.3.2. Germany Breast Cancer Diagnostics Market
7.3.3. Rest of Europe Breast Cancer Diagnostics Market
7.4. Asia-Pacific Breast Cancer Diagnostics Market Snapshot
7.4.1. China Breast Cancer Diagnostics Market
7.4.2. India Breast Cancer Diagnostics Market
7.4.3. Japan Breast Cancer Diagnostics Market
7.4.4. Rest of Asia Pacific Breast Cancer Diagnostics Market
7.5. Latin America Breast Cancer Diagnostics Market Snapshot
7.5.1. Brazil Breast Cancer Diagnostics Market
7.5.2. Mexico Breast Cancer Diagnostics Market
7.6. Rest of The World Breast Cancer Diagnostics Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Hologic Inc.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. GE Healthcare
8.2.3. Phillips Healthcare
8.2.4. Fujifilm Holdings Corporation
8.2.5. Gamma Medica Inc.
8.2.6. Toshiba Corporation
8.2.7. Aurora Imaging Technology Inc.
8.2.8. Dilion Technologies Inc.
8.2.9. Genomic Health
8.2.10. NanoString Technologies, Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption



List of Figures


FIG 1. GLOBAL BREAST CANCER DIAGNOSTICS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL BREAST CANCER DIAGNOSTICS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL BREAST CANCER DIAGNOSTICS MARKET, KEY TRENDS 2019
FIG 5. GLOBAL BREAST CANCER DIAGNOSTICS MARKET, GROWTH PROSPECTS 2020-2026
FIG 6. GLOBAL BREAST CANCER DIAGNOSTICS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL BREAST CANCER DIAGNOSTICS MARKET, PEST ANALYSIS
FIG 8. GLOBAL BREAST CANCER DIAGNOSTICS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. GLOBAL BREAST CANCER DIAGNOSTICS MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA BREAST CANCER DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 16. EUROPE BREAST CANCER DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 17. ASIA PACIFIC BREAST CANCER DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 18. LATIN AMERICA BREAST CANCER DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 19. GLOBAL BREAST CANCER DIAGNOSTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)


List of Tables


TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL BREAST CANCER DIAGNOSTICS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL BREAST CANCER DIAGNOSTICS MARKET
TABLE 3. GLOBAL BREAST CANCER DIAGNOSTICS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY DIAGNOSTIC TYPE 2016-2026 (USD BILLION)
TABLE 8. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD BILLION)
TABLE 9. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 10. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. U.S. BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. U.S. BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 21. U.S. BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 22. CANADA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. CANADA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 24. CANADA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 25. UK BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. UK BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 27. UK BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. GERMANY BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. GERMANY BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. GERMANY BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. ROE BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 32. ROE BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. ROE BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. CHINA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 35. CHINA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. CHINA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. INDIA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 38. INDIA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. INDIA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. JAPAN BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 41. JAPAN BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. JAPAN BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. ROAPAC BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 44. ROAPAC BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. ROAPAC BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. BRAZIL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 47. BRAZIL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. BRAZIL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. MEXICO BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 50. MEXICO BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. MEXICO BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. ROLA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 53. ROLA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. ROLA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. ROW BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 56. ROW BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. ROW BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)